AGM/EGMJun 17, 2026, 05:01 PM
Biodexa Pharmaceuticals AGM Adjourned, Rescheduled for June 30
AI Summary
Biodexa Pharmaceuticals PLC announced that its Annual General Meeting (AGM), originally scheduled for June 17, 2026, was adjourned due to a lack of quorum. The company has re-scheduled the AGM to take place on June 30, 2026, at 11:00 a.m. London time, at its registered office in Cardiff. Proxies submitted for the initial meeting will remain valid for the re-scheduled AGM.
Key Highlights
- Biodexa Pharmaceuticals PLC's Annual General Meeting (AGM) on June 17, 2026, was adjourned.
- The adjournment was due to a lack of quorum.
- The AGM has been re-scheduled for June 30, 2026, at 11:00 a.m. (London time).
- The re-scheduled AGM will take place at the Company's registered office in Cardiff, Wales.
- Proxies submitted for the original AGM will remain valid for the re-scheduled meeting.
Price Impact
More from BDRX